Cargando…

Glycans as Potential Diagnostic Markers of Traumatic Brain Injury

The diagnosis of mild traumatic brain injury (TBI) is challenging in the acute setting because the symptoms are nonspecific and often transient, or they develop with a delay. In these cases, the criteria for acute head imaging are frequently not fulfilled. This may lead to missed diagnoses in emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvist, Mårten, Välimaa, Lasse, Harel, Adrian, Posti, Jussi P., Rahi, Melissa, Saarenpää, Ilkka, Visuri, Mikko, Östberg, Anna, Rinne, Jaakko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615782/
https://www.ncbi.nlm.nih.gov/pubmed/34827479
http://dx.doi.org/10.3390/brainsci11111480
_version_ 1784604188632678400
author Kvist, Mårten
Välimaa, Lasse
Harel, Adrian
Posti, Jussi P.
Rahi, Melissa
Saarenpää, Ilkka
Visuri, Mikko
Östberg, Anna
Rinne, Jaakko
author_facet Kvist, Mårten
Välimaa, Lasse
Harel, Adrian
Posti, Jussi P.
Rahi, Melissa
Saarenpää, Ilkka
Visuri, Mikko
Östberg, Anna
Rinne, Jaakko
author_sort Kvist, Mårten
collection PubMed
description The diagnosis of mild traumatic brain injury (TBI) is challenging in the acute setting because the symptoms are nonspecific and often transient, or they develop with a delay. In these cases, the criteria for acute head imaging are frequently not fulfilled. This may lead to missed diagnoses in emergency care. There is a need for developing a rapid diagnostic test to verify the presence of TBI using body fluids. Blood, urine, and saliva samples from 11 adult patients (mean age 64 years, SD 24 years) with acute and clinically diagnosed TBI, and 12 healthy volunteers were collected at Turku University Hospital during a period of 5 months. The injuries necessitated hospitalization for at least one day. The TBIs were classified mild in nine cases and severe in two cases. The mean period between the trauma and the time for obtaining the samples was 27 h, SD 11 h. The samples were analyzed in an ISO-certified laboratory for the number of lectin-bound glycan molecules indicating destruction of nerve tissue. The screening was performed on several possible glycans for binding, and the measurement by degree of fluorescence. In the analysis, the group of patients with TBI was compared with healthy volunteers. The results showed a significant decrease (p < 0.05, Wilcoxon rank–sum two-sided test) in the level of two glycans in plasma, but no significant increase for any glycan; in saliva, one glycan showed a significant increase in the TBI group; in urine, three glycans were significantly different between the groups (one showed an increase, whereas two showed a decrease). The results support the idea of conducting more research on how diagnostic glycans could be detected in body fluids after TBI. As a proof-of-concept, significant changes in the concentration of five glycans were found in plasma, saliva, and urine between TBI patients and healthy controls. This may enable the development of a rapid body fluid-based point-of-care test to identify patients with TBI after a head injury.
format Online
Article
Text
id pubmed-8615782
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86157822021-11-26 Glycans as Potential Diagnostic Markers of Traumatic Brain Injury Kvist, Mårten Välimaa, Lasse Harel, Adrian Posti, Jussi P. Rahi, Melissa Saarenpää, Ilkka Visuri, Mikko Östberg, Anna Rinne, Jaakko Brain Sci Article The diagnosis of mild traumatic brain injury (TBI) is challenging in the acute setting because the symptoms are nonspecific and often transient, or they develop with a delay. In these cases, the criteria for acute head imaging are frequently not fulfilled. This may lead to missed diagnoses in emergency care. There is a need for developing a rapid diagnostic test to verify the presence of TBI using body fluids. Blood, urine, and saliva samples from 11 adult patients (mean age 64 years, SD 24 years) with acute and clinically diagnosed TBI, and 12 healthy volunteers were collected at Turku University Hospital during a period of 5 months. The injuries necessitated hospitalization for at least one day. The TBIs were classified mild in nine cases and severe in two cases. The mean period between the trauma and the time for obtaining the samples was 27 h, SD 11 h. The samples were analyzed in an ISO-certified laboratory for the number of lectin-bound glycan molecules indicating destruction of nerve tissue. The screening was performed on several possible glycans for binding, and the measurement by degree of fluorescence. In the analysis, the group of patients with TBI was compared with healthy volunteers. The results showed a significant decrease (p < 0.05, Wilcoxon rank–sum two-sided test) in the level of two glycans in plasma, but no significant increase for any glycan; in saliva, one glycan showed a significant increase in the TBI group; in urine, three glycans were significantly different between the groups (one showed an increase, whereas two showed a decrease). The results support the idea of conducting more research on how diagnostic glycans could be detected in body fluids after TBI. As a proof-of-concept, significant changes in the concentration of five glycans were found in plasma, saliva, and urine between TBI patients and healthy controls. This may enable the development of a rapid body fluid-based point-of-care test to identify patients with TBI after a head injury. MDPI 2021-11-09 /pmc/articles/PMC8615782/ /pubmed/34827479 http://dx.doi.org/10.3390/brainsci11111480 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kvist, Mårten
Välimaa, Lasse
Harel, Adrian
Posti, Jussi P.
Rahi, Melissa
Saarenpää, Ilkka
Visuri, Mikko
Östberg, Anna
Rinne, Jaakko
Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title_full Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title_fullStr Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title_full_unstemmed Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title_short Glycans as Potential Diagnostic Markers of Traumatic Brain Injury
title_sort glycans as potential diagnostic markers of traumatic brain injury
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615782/
https://www.ncbi.nlm.nih.gov/pubmed/34827479
http://dx.doi.org/10.3390/brainsci11111480
work_keys_str_mv AT kvistmarten glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT valimaalasse glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT hareladrian glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT postijussip glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT rahimelissa glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT saarenpaailkka glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT visurimikko glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT ostberganna glycansaspotentialdiagnosticmarkersoftraumaticbraininjury
AT rinnejaakko glycansaspotentialdiagnosticmarkersoftraumaticbraininjury